These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 9349473)
21. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Daniel MD; Kirchhoff F; Czajak SC; Sehgal PK; Desrosiers RC Science; 1992 Dec; 258(5090):1938-41. PubMed ID: 1470917 [TBL] [Abstract][Full Text] [Related]
22. Live attenuated, nef-deleted SIV is pathogenic in most adult macaques after prolonged observation. Hofmann-Lehmann R; Vlasak J; Williams AL; Chenine AL; McClure HM; Anderson DC; O'Neil S; Ruprecht RM AIDS; 2003 Jan; 17(2):157-66. PubMed ID: 12545074 [TBL] [Abstract][Full Text] [Related]
23. Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection. Petry H; Dittmer U; Stahl-Hennig C; Coulibaly C; Makoschey B; Fuchs D; Wachter H; Tolle T; Morys-Wortmann C; Kaup FJ J Virol; 1995 Mar; 69(3):1564-74. PubMed ID: 7853490 [TBL] [Abstract][Full Text] [Related]
25. Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. Letvin NL; Li J; Halloran M; Cranage MP; Rud EW; Sodroski J J Virol; 1995 Jul; 69(7):4569-71. PubMed ID: 7769725 [TBL] [Abstract][Full Text] [Related]
26. Vaccine effect using a live attenuated nef-deficient simian immunodeficiency virus of African green monkeys in the absence of detectable vaccine virus replication in vivo. Beer B; Baier M; zur Megede J; Norley S; Kurth R Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4062-7. PubMed ID: 9108105 [TBL] [Abstract][Full Text] [Related]
27. Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIV(macJ5) on the kinetics of SIV replication in cynomolgus monkeys. Negri DR; Baroncelli S; Michelini Z; Macchia I; Belli R; Catone S; Incitti F; ten Haaft P; Corrias F; Cranage MP; Polyanskaya N; Norley S; Heeney J; Verani P; Titti F J Med Primatol; 2001 Aug; 30(4):197-206. PubMed ID: 11555138 [TBL] [Abstract][Full Text] [Related]
28. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Baba TW; Jeong YS; Pennick D; Bronson R; Greene MF; Ruprecht RM Science; 1995 Mar; 267(5205):1820-5. PubMed ID: 7892606 [TBL] [Abstract][Full Text] [Related]
29. An attenuated vaccine for AIDS? Beale J Lancet; 1995 May; 345(8961):1318-9. PubMed ID: 7752750 [TBL] [Abstract][Full Text] [Related]
30. Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques. Byrareddy SN; Ayash-Rashkovsky M; Kramer VG; Lee SJ; Correll M; Novembre FJ; Villinger F; Johnson WE; von Gegerfelt A; Felber BK; Ruprecht RM PLoS One; 2013; 8(9):e75556. PubMed ID: 24098702 [TBL] [Abstract][Full Text] [Related]
31. "Attenuated" simian immunodeficiency virus in macaque neonates. Ruprecht RM; Baba TW; Liska V; Bronson R; Penninck D; Greene MF AIDS Res Hum Retroviruses; 1996 Mar; 12(5):459-60. PubMed ID: 8882333 [No Abstract] [Full Text] [Related]
32. Live attenuated AIDS viruses as vaccines: promise or peril? Ruprecht RM Immunol Rev; 1999 Aug; 170():135-49. PubMed ID: 10566148 [TBL] [Abstract][Full Text] [Related]
33. Nef from pathogenic simian immunodeficiency virus is a negative factor for vaccinia virus. Chan KS; Verardi PH; Legrand FA; Yilma TD Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8734-9. PubMed ID: 15930136 [TBL] [Abstract][Full Text] [Related]
35. A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. Alexander L; Du Z; Rosenzweig M; Jung JU; Desrosiers RC J Virol; 1997 Aug; 71(8):6094-9. PubMed ID: 9223503 [TBL] [Abstract][Full Text] [Related]
36. Resistance of neonatal monkeys to live attenuated vaccine strains of simian immunodeficiency virus. Wyand MS; Manson KH; Lackner AA; Desrosiers RC Nat Med; 1997 Jan; 3(1):32-6. PubMed ID: 8986737 [TBL] [Abstract][Full Text] [Related]
37. Live attenuated SIV--a model of a vaccine for AIDS. Almond N; Stott J Immunol Lett; 1999 Mar; 66(1-3):167-70. PubMed ID: 10203050 [TBL] [Abstract][Full Text] [Related]
38. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine. Desrosiers RC AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412 [No Abstract] [Full Text] [Related]
39. Absence of a correlation between humoral and cellular responses to a vaccinia virus and products of the major histocompatibility complex in rhesus monkeys. Stitz L; Kreeftenberg JG; Loggen HG; Balner H Antiviral Res; 1981 Sep; 1(3):193-9. PubMed ID: 7337432 [TBL] [Abstract][Full Text] [Related]
40. Live HIV vaccines--how safe? Dittmer U; Stahl-Hennig C; Hunsmann G Nat Med; 1997 Aug; 3(8):816. PubMed ID: 9256262 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]